CWM
AGIO icon

CIBC World Markets’s Agios Pharmaceuticals AGIO Stock Holding History

CIBC World Markets’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$231K Sell
6,959
-5,582
-45% -$169K ﹤0.01% 1214
2025
Q1 		$367K Buy
+12,541
New +$416K ﹤0.01% 1156

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC World Markets's AGIO Position: Q2 2025 in Review

CIBC World Markets reduced its Agios Pharmaceuticals (AGIO) stake by 45% in Q2 2025, selling an estimated $169K and leaving 6,959 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #1214.

CIBC World Markets first reported a position in AGIO in Q1 2025 and has held it in 2 quarters since. The position peaked at $367K in Q1 2025. 214 funds tracked by Wall St. Rank hold AGIO as of Q2 2025.

  • CIBC World Markets held 6,959 shares of Agios Pharmaceuticals worth $231K as of Q2 2025.
  • CIBC World Markets sold 5,582 Agios Pharmaceuticals shares in Q2 2025, an estimated $169K.
  • Agios Pharmaceuticals made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1214 holding.
  • CIBC World Markets first reported a position in Agios Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • CIBC World Markets's Agios Pharmaceuticals position peaked at $367K in Q1 2025.
  • 214 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.